Effects of a gastrin-releasing peptide receptor antagonist on D-amphetamine-induced oxidative stress in the rat brain

Journal of Neural Transmission

Volumn 117, Issue 3, 2010, Pages 309-316

  Valvassori, Samira S ^a   Moretti, Morgana ^a   Kauer SanT'Anna, Mareia ^b   Roesler, Rafael ^b,c   Petronilho, Fabrícia ^c   Schwartsmann, Gilberto ^b   Kapczinski, Flavio ^b   Dal Pizzol, Felipe ^c   Quevedo, João ^a,d  

^a UNIVERSITY OF SOUTHERN SANTA CATARINA   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^d UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

Author keywords

Bombesin like peptides; Gastrin releasing peptide receptor; Mania bipolar disorder; Oxidative stress; RC 3095

Indexed keywords

BOMBESIN ANTAGONIST; CARBONYL DERIVATIVE; CATALASE; DEXAMPHETAMINE; RC 3095; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; HIPPOCAMPUS; LOCOMOTION; MALE; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REARING;

ANIMALS; ANTIOXIDANTS; BOMBESIN; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; CEREBRAL CORTEX; DEXTROAMPHETAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; MALE; MOTOR ACTIVITY; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; RECEPTORS, BOMBESIN; TIME FACTORS;

EID: 77952429018     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-010-0373-z     Document Type: Article

References (34)

1. Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121-126
2. Andreazza AC, Cassini C, Rosa AR, Leite MC, de Almeida LM, Nardin P, Cunha AB, Ceresér KM, Santin A, Gottfried C, Salvador M, Kapczinski F, Gonçalves CA (2007) Serum S100B and antioxidant enzymes in bipolar patients. J Psychiatr Res 41:523-529 (Pubitemid 46227446)
3. Andreazza AC, Kauer-Sant'Anna M, Frey BN, Stertz L, Zanotto C, Ribeiro L, Giasson K, Valvassori SS, Réus GZ, Salvador M, Quevedo J, Gonçalves CA, Kapczinski F (2008) DNA damage in bipolar disorder. J Psychiatr Neurosci 33:516-524
4. Arban R, Maraia G, Brackenborough K, Winyard L, Wilson A, Gerrard P, Large C (2005) Evaluation of the effects of ~lamotrigine, valproate and carbamazepine in a rodent model of mania. Behav Brain Res 158:123-132 (Pubitemid 40174717)
5. Assimakopoulos SF, Alexandris IH, Scopa CD, Mylonas PG, Thomopoulos KC, Georgiou CD, Nikolopoulou VN, Vagianos CE (2005a) Effect of bombesin and neurotensin on gut barrier function in partially hepatectomized rats. World J Gastroenterol 11:6757-6764 (Pubitemid 43092444)
6. Assimakopoulos SF, Scopa CD, Zervoudakis G, Mylonas PG, Georgiou C, Nikolopoulou V, Vagianos CE (2005b) Bombesin and neurotensin reduce endotoxemia, intestinal oxidative stress, and apoptosis in experimental obstructive jaundice. Ann Surg 41:159-167 (Pubitemid 40041005)
7. Cornelio DB, Roesler R, Schwartsmann G (2007) Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy. Ann Oncol 18:1457-1466 (Pubitemid 47365477)
8. Dal-Pizzol F, Di Leone LP, Ritter C, Martins MR, Reinke A, Pens GD, Zanotto-Filho A, de Souza LF, Andrades M, Barbeiro DF, Bernard EA, Cammarota M, Bevilaqua LR, Soriano FG, Cláudio J, Moreira F, Roesler R, Schwartsmann G (2006) Gastrinreleasing peptide receptor antagonist effects on an animal model of sepsis. Am J Respir Crit Care Med 173:84-90
9. Dantas Ados S, Luft T, Henriques JA, Schwartsmann G, Roesler R (2006) Opposite effects of low and high doses of the gastrinreleasing peptide receptor antagonist RC-3095 on memory consolidation in the hippocampus: possible involvement of the GABAergic system. Peptides 27:2307-2312 (Pubitemid 44189622)
10. Draper HH, Hadley M (1990) Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 186:421-431
11. Frey BN, Andreazza AC, Cereser KM, Martins MR, Petronilho FC, de Souza DF, Tramontina F, Gonçalves CA, Quevedo J, Kapczinski F (2006a) Evidence of astrogliosis in rat hippocampus after D-amphetamine exposure. Prog Neuropsychopharmacol Biol Psychiatry 30:1231-1234 (Pubitemid 44216059)
12. Frey BN, Andreazza AC, Cereser KM, Martins MR, Valvassori SS, Reus GZ, Quevedo J, Kapczinski F (2006b) Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania. Life Sci 79:281-286 (Pubitemid 43782552)
13. Frey BN, Andreazza AC, Rosa AR, Martins MR, Valvassori SS, Reus GZ, Hatch JP, Quevedo J, Kapczinski F (2006c) Lithium increases nerve growth factor levels in the rat hippocampus in an animal model of mania. Behav Pharmacol 17:311-318
14. Frey BN, Martins MR, Petronilho FC, Dal-Pizzol F, Quevedo J, Kapczinski F (2006d) Increased oxidative stress after repeated amphetamine exposure: possible relevance as a model of mania. Bipolar Disord 8:275-280
15. Frey BN, Valvassori SS, Reus GZ, Martins MR, Petronilho F, Bardini CK, Dal-Pizzol F, Kapczinski F, Quevedo J (2006e) Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania. J Psychiatry Neurosci 31:326-332
16. Frey BN, Valvassori SS, Reus GZ, Martins MR, Petronilho FC, Bardini K, Dal-Pizzol F, Kapczinski F, Quevedo J (2006f) Changes in antioxidant defense enzymes after D-amphetamine exposure: implications as an animal model of mania. Neurochem Res 31:699-703
17. Frey BN, Andreazza AC, Kunz M, Gomes FA, Quevedo J, Salvador M, Gonçalves CA, Kapczinski F (2007) Increased oxidative stress and DNA damage in bipolar disorder: a twin-case report. Prog.Neuropsychopharmacol Biol Psychiatry 31:283-285 (Pubitemid 46019782)
18. Gibson GE, Huang HM (2004) Mitochondrial enzymes and endoplasmic reticulum calcium, stores as targets of oxidative stress in neurodegenerative diseases. J Bioenerg Biomembr 36:335-340
19. Gould TD, O'Donnell KC, Picchini AM, Manji HK (2007) Strain differences in lithium attenuation of d-amphetamine-induced hyperlocomotion: a mouse model for the genetics of clinical. response to lithium. Neuropsychopharmacology 32:1321-1333
20. Heikkila R, Trepei JB, Cuttitta F, Neckers LM, Sausville EA (1987) Bombesin-related peptides induce calcium mobilization in a subset of human small cell lung cancer cell lines. J Biol Chem 262:16456-16460 (Pubitemid 18006062)
21. Iacovelli L, Fulceri F, De Blasi A, Nicoletti F, Ruggieri S, Fornai F (2006) The neurotoxicity of amphetamines: bridging drugs of abuse and neurodegenerative disorders. Exp Neurol 201:24-31 (Pubitemid 44223465)
22. Kauer-Sant'Anna M, Andreazza AC, Valvassori SS, Martins MR, Barbosa LM, Schwartsmann G, Roesler R, Quevedo J, Kapczinski F (2007) A gastrin-releasing peptide receptor antagonist blocks D-amphetamine-induced hyperlocomotion and increases hippocampal NGF and BDNF levels in rats. Peptides 28:1447-1452 (Pubitemid 47096749)
23. Kelly MP, Logue SF, Dwyer JM, Beyer CE, Majchrowski H, Cai Z, Liu Z, Adedoyin A, Rosenzweig-Lipson S, Comery TA (2009) The supra-additive hyperactivity caused by an amphetaminechlordiazepoxide mixture exhibits an inverted-U dose response: negative implications for the use of a model in screening for mood stabilizers. Pharmacol Biochem Behav 92:649-654
24. Kunz M, Gama CS, Andreazza AC, Salvador M, Cereser KM, Gomes FA, Belmonte-de-Abreu PS, Berk M, Kapczinski F (2008) Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 32:1677-1681
25. Levine RL, Williams JA, Stadtman ER, Shacter E (1994) Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 233:346-357 (Pubitemid 24177560)
26. Marklund SL (1985) Product of extracellular-superoxide dismutase catalysis. FEBS Lett 184:237-239
27. Meiler CA, Henriques JA, Schwartsmann G, Roesler R (2004) The bombesin/gastrin releasing peptide receptor antagonist RC-3095 blocks apomorphine but not MK-801-induced stereotypy in mice. Peptides 25:585-588 (Pubitemid 38681057)
28. Musavi S, Kakkar P (1998) Diazepam induced early oxidative changes at the subcellular level in rat brain. Mol Cell Biochem 178:41-46 (Pubitemid 28121739)
29. Musavi S, Kakkar P (2000) Pro and antioxidant responses to repeated administration of diazepam in rat brain. Mol Cell Biochem 206:97-103 (Pubitemid 30246511)
30. Musavi S, Kakkar P (2003) Effect of diazepam treatment and its withdrawal on pro/antioxidative processes in rat brain. Mol Cell Biochem. 245:51-56 (Pubitemid 36416821)
31. Roesler R, Henriques JA, Schwartsmann G (2004) Neuropeptides and anxiety disorders: bombesin receptors as novel therapeutic targets. Trends Pharmacol Sci 25:241-242 (Pubitemid 38553824)
32. Roesler R, Henriques JA, Schwartsmann G (2006a) Gastrin-releasing peptide receptor as a molecular target for psychiatric and neurological disorders. CNS Neurol Disord Drug Targets 5:197-204 (Pubitemid 43796620)
33. Roesler R, Luft T, Oliveira SH, Farias CB, Almeida VR, Quevedo J, Dal Pizzol F, Schröder N, Izquierdo I, Schwartsmann G (2006b) Mechanisms mediating gastrin-releasing peptide receptor modulation of memory consolidation in the hippocampus. Neuropharmacology 51:350-357
34. Szabo ST, Machado-Vieira R, Yuan P, Wang Y, Wei Y, Falke C, Cirelli C, Tononi G, Manji HK, Du J (2009) Glutamate receptors as targets of protein kinase C in the pathophysiology and treatment of animal models of mania. Neuropharmacology 56:47-55